Structure-Activity Relationships of 2 side chain to 2-thioisocephem having hydroxyiminoaminothiazol at the C-7 position. As shown in Table 2, anti-MRSA-70 activities of these compounds were 3. 13, 12.5 and 0.78/ig/ml, respectively.
TOC-29, bearing
Af-carbamoylmethyl-pyridinumthiovinyl at the C-3 position and hydroxyimino-aminothiazol at the C-7 position, showed the best activity against MRSA-70in the comparison with the other compounds.In addition, as seen in Table 3 , TOC-29 showed an excellent activity against clinically isolated MRSA-70 compared with the reference compound flomoxef. The MIC-80, which is that concentration of drug required to inhibit 80% of the growth of the strains tested, of TOC-24, TOC-25, and TOC-29 against clinically isolated MRSAwas 100, > 100, and 6.25/ig/ml, respectively (Fig. 1) . Reports investigating the activity against MRSAof 2-thioiso- (Table 3) . Antibacterial activities of TOC-29, TOC-8, TOC-15, and TOC-02 against MRSA 70 were 0.78, 25, >100, and 25/xg/ml, respectively (Table 3) . These results taken together show that the anti-MRSA activity was strongly enhanced by the nature of a linker at the C-3 position and by that of an aminothiazol-oximesubstituent at the C-7 position. This research approach shows great promise in the search for novel cephems with anti-MRSA activity.
Antibacterial activities of TOC-compounds except for TOC-01, and TOC-15 showed similar good activities Tables 1, 2 , and 3. However, these activities were not related to the anti-MRSA activities. Accordingly, we speculate that the anti-MRSAactivities might be caused by high affinity of TOC-compoundsfor penicillin-binding protein 2' (PBP2'), since the key player in MRSAresistance is known to be PBP2'8'9). TOC-29 exhibiting potent activity against MRSA-70 showed further a good activity against E. faecalis ATCC-12968, which becamespontaneously resistant to cephemantibiotics (Table 2) . Antibacterial activity of TOC-compounds against E. faecalis ATCC-12968 paralleled their anti-MRSA activity (Tables 1 -3 
